Cargando…

Cathelicidin-related Antimicrobial Peptide Contributes to Host Immune Responses Against Pulmonary Infection with Acinetobacter baumannii in Mice

Acinetobacter baumannii is known for its multidrug antibiotic resistance. New approaches to treating drug-resistant bacterial infections are urgently required. Cathelicidin-related antimicrobial peptide (CRAMP) is a murine antimicrobial peptide that exerts diverse immune functions, including both di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Min-Jung, Jang, Ah-Ra, Park, Ji-Yeon, Ahn, Jae-Hun, Lee, Tae-Sung, Kim, Dong-Yeon, Jung, Do-Hyeon, Song, Eun-Jung, Hong, Jung Joo, Park, Jong-Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327154/ https://www.ncbi.nlm.nih.gov/pubmed/32655973 http://dx.doi.org/10.4110/in.2020.20.e25

Ejemplares similares

Nucleotide-binding oligomerization domain 1 is dispensable for host immune responses against pulmonary infection of Acinetobacter baumannii in mice
por: Kang, Min-Jung, et al.
Publicado: (2018)

IL-10 Protects Mice From the Lung Infection of Acinetobacter baumannii and Contributes to Bacterial Clearance by Regulating STAT3-Mediated MARCO Expression in Macrophages
por: Kang, Min-Jung, et al.
Publicado: (2020)

Computational screening of antimicrobial peptides for Acinetobacter baumannii
por: Majumder, Ayan, et al.
Publicado: (2019)

Systemic Responses of Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Following Exposure to the Antimicrobial Peptide Cathelicidin-BF Imply Multiple Intracellular Targets
por: Liu, Cunbao, et al.
Publicado: (2017)

Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia
por: Jung, Chiau-Jing, et al.
Publicado: (2021)

Synergistic Effects of a Probiotic Culture Extract and Antimicrobial Combinations against Multidrug-Resistant Acinetobacter baumannii
por: Lee, Ji Hyeon, et al.
Publicado: (2023)

Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs against Acinetobacter baumannii
por: Hong, Min Ji, et al.
Publicado: (2021)

Cathelicidin Antimicrobial Peptide Acts as a Tumor Suppressor in Hepatocellular Carcinoma
por: Huang, Lien-Hung, et al.
Publicado: (2023)

Risk Factors for Mortality in Patients with Acinetobacter baumannii Bacteremia
por: Park, Se Yoon, et al.
Publicado: (2013)

Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2022)

An Update on the Therapeutic Potential of Antimicrobial Peptides against Acinetobacter baumannii Infections
por: Rangel, Karyne, et al.
Publicado: (2023)

Oral Administration of Lactobacillus sakei CVL-001 Improves Recovery from Dextran Sulfate Sodium-Induced Colitis in Mice by Microbiota Modulation
por: Kim, Dong-Yeon, et al.
Publicado: (2023)

Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii
por: Jaśkiewicz, Maciej, et al.
Publicado: (2018)

Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Infection
por: Choi, Joonhyeok, et al.
Publicado: (2021)

1855. Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
por: Lee, Chan Mi, et al.
Publicado: (2022)

Cathelicidins: family of antimicrobial peptides. A review
por: Kościuczuk, Ewa M., et al.
Publicado: (2012)

Snake Venom Cathelicidins as Natural Antimicrobial Peptides
por: de Barros, Elizângela, et al.
Publicado: (2019)

Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
por: Zhang, Qing, et al.
Publicado: (2023)

DksA Modulates Antimicrobial Susceptibility of Acinetobacter baumannii
por: Kim, Nayeong, et al.
Publicado: (2021)

Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
por: Shin, Jung Ar, et al.
Publicado: (2012)

Acinetobacter baumannii Outer Membrane Vesicles Elicit a Potent Innate Immune Response via Membrane Proteins
por: Jun, So Hyun, et al.
Publicado: (2013)

Type I Interferons Are Involved in the Intracellular Growth Control of Mycobacterium abscessus by Mediating NOD2-Induced Production of Nitric Oxide in Macrophages
por: Ahn, Jae-Hun, et al.
Publicado: (2021)

Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea
por: Kim, Chung-Jong, et al.
Publicado: (2022)

Clinical Use of Colistin Induces Cross-Resistance to Host Antimicrobials in Acinetobacter baumannii
por: Napier, Brooke A., et al.
Publicado: (2013)

Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2021)

The Antimicrobial Peptide Octopromycin Suppresses Biofilm Formation and Quorum Sensing in Acinetobacter baumannii
por: Rajapaksha, Dinusha Chathurangi, et al.
Publicado: (2023)

Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
por: Lee, Chang-Ro, et al.
Publicado: (2017)

Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy
por: Kim, Youn Jeong, et al.
Publicado: (2012)

Nosocomial Outbreak of Carbapenem-Resistant Acinetobacter baumannii in Intensive Care Units and Successful Outbreak Control Program
por: Choi, Won Suk, et al.
Publicado: (2010)

Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds
por: van Eijk, Martin, et al.
Publicado: (2020)

Wound healing mechanism of antimicrobial peptide cathelicidin-DM
por: Wang, Guixi, et al.
Publicado: (2022)

D-galactose Intake Alleviates Atopic Dermatitis in Mice by Modulating Intestinal Microbiota
por: Kim, Dong-Yeon, et al.
Publicado: (2022)

OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii
por: Lin, Ming-Feng, et al.
Publicado: (2015)

Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Acinetobacter baumannii in vitro and in vivo
por: Peng, Jian, et al.
Publicado: (2023)

Molecular and Epidemiological Characterization of Carbapenem-Resistant Acinetobacter baumannii in Non-Tertiary Korean Hospitals
por: Park, Sunok, et al.
Publicado: (2013)

Clinical impact of COVID-19 in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia
por: Kim, Jeong Yeon, et al.
Publicado: (2023)

The resistance mechanisms of b-lactam antimicrobials in clinical isolates of Acinetobacter baumannii
por: Kwon, Na Young, et al.
Publicado: (2002)

The role of Zur-regulated lipoprotein A in bacterial morphology, antimicrobial susceptibility, and production of outer membrane vesicles in Acinetobacter baumannii
por: Kim, Nayeong, et al.
Publicado: (2021)

Antifibrogenic Effects of the Antimicrobial Peptide Cathelicidin in Murine Colitis-Associated Fibrosis
por: Yoo, Jun Hwan, et al.
Publicado: (2014)

Cathelicidins: Immunomodulatory Antimicrobials
por: van Harten, Roel M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cm8sfk5es5uj7rsgnultvg6v1h